Real-world effectiveness of dupilumab in patients with asthma: findings from the United States ADVANTAGE study
Description
CONCLUSION: Current real-world efficacy evidence indicates that dupilumab reduces asthma exacerbations and total SCS prescriptions in clinical practice. The effectiveness of dupilumab was observed independent of exacerbation history, EOS levels, or
